Seed is a microbiome science company founded in 2018 by Ara Katz and Raja Dhir, focused on developing clinically studied probiotics backed by rigorous scientific research. The company's flagship product, DS-01 Daily Synbiotic, is a 2-in-1 prebiotic and probiotic formulation containing 24 clinically and genomically characterized probiotic strains and a prebiotic blend of punicalagins from Indian pomegranate. Seed has built its brand on scientific credibility, publishing research in peer-reviewed journals and maintaining a scientific advisory board of leading microbiome researchers.
The Seed website offers its DS-01 Daily Synbiotic in subscription format for both adults and a PDS-08 Pediatric Daily Synbiotic for children, with all products delivered in a refillable glass jar system to reduce packaging waste. The brand's proprietary ViaCap delivery technology uses a nested capsule design to ensure probiotic survival through stomach acid and bile salts for targeted release in the colon. Seed also runs SeedLabs, a research and development arm that funds and conducts clinical trials on the human microbiome.